Follows people with kidney disease in China over time
Observes people newly diagnosed with or living with kidney disease in China.
Plain-language title generated from the registry record
Registry title: China Kidney Patient Trials Network
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people in China with a diagnosed primary kidney disease who see a doctor at a taking-part site at least every 6 months.
- Age
- 2 years or older
- Sex
- All sexes can join
- Disease stage
- Documented diagnosis of primary kidney disease; eGFR above 15 ml/min/1.73 m2
- Biomarker or test result
- eGFR above 15 ml/min/1.73 m2
Main reasons for not taking part
- Life expectancy of less than 6 months
Read by machine on 9 November 2026.
Where in China
- George Clinical (Beijing)Beijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- George (Beijing) Clinical Research Co. Ltd.
- Trial code
- NCT05036850
- Record updated
- 6 March 2023
- Original description
This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.Read full original descriptionShow less
China Kidney Patient Trials Network
This is a prospective multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease in China.
Inclusion: Documented diagnosis of primary kidney disease; Regular visits (at least 6 monthly) with a physician at a participating site; eGFR > 15 ml/min/1.73 m2; ≥ 2 years of age; Willing and able to sign informed consent; Willing to be approached about participation in interventional research studies.
Exclusion: 1. Life-expectancy of less than 6 months.